Comparative study of the efficacy of gentamicin-coated intramedullary interlocking nail versus regular intramedullary interlocking nail in Gustilo type I and II open tibia fractures

Deepak Pinto, K Manjunatha, Amarnath D Savur, Naufal Rizwan Ahmed, Sharan Mallya, V Ramya, Deepak Pinto, K Manjunatha, Amarnath D Savur, Naufal Rizwan Ahmed, Sharan Mallya, V Ramya

Abstract

Purpose: Open tibia fracture is prone to infection, consequently causing significant morbidity and increasing the hospital stay, occupational loss and onset of chronic osteomyelitis. Intramedullary nailing is one choice for treating tibia shaft fractures. To improve the delivery of antibiotics at the tissue-implant interface, many methods have been proposed as a part of prophylaxis against infection. This study was conducted to study the role of gentamicin-impregnated intramedullary interlocking (IMIL) nail in the prevention of infection in Gustilo type I and II open tibia fractures and to compare the results with regular intramedullary nail.

Methods: The study included 28 patients with open tibia fractures (Gustilo type 1 or type 2); of them 14 underwent regular IMIL nailing and the other 14 were treated with gentamicin-coated nailing. Randomization was done by alternate allocation of the patients. Follow-up was done postoperatively (day 1), 1 week, 6 weeks, and 6 months for bone union, erythrocyte sedimentation rate (ESR), hemoglobin and C-reactive protein (CRP). Statistical significance was tested using unpaired t-test. A p value less than 0.05 was considered significant.

Results: There were 4 cases of infection in controls (regular IMIL nail) and no infection among patients treated with gentamicin-coated nail during the follow up (X2 = 4.66, p = 0.031). At 6 months postoperatively, CRP (p = 0.031), ESR (p = 0.046) and hemoglobin level (p = 0.016) showed significant difference between two groups. The bone healing rate was better with gentamicin-coated nail in comparison to regular IMIL nail at 6 months follow-up (p = 0.016).

Conclusion: Gentamicin-coated IMIL nail has a positive role in preventing infection in Gustilo type I and II open tibia fractures.

Keywords: Antibiotic impregnated nail; Infection; Intramedullary nailing; Open tibia fracture.

Copyright © 2019 Chinese Medical Association. Production and hosting by Elsevier B.V. All rights reserved.

Figures

Fig. 1
Fig. 1
Fracture healing at 6 weeks and 6 months postoperatively. The numbers in the bars indicate the number of patients with 0, 1, 2, 3 or 4 bridged cortices at each follow-up visit.
Fig. 2
Fig. 2
A 28-year-old male with type II open tibia fractures was treated with gentamicin-coated nail. Preoperative lateral (A) and anteroposterior (B) X-ray and 6 months follow-up X-ray (C) showing fracture healing.

References

    1. Court-Brown C.M., McBirnie J. The epidemiology of tibial fractures. J Bone Joint Surg Br. 1995;77:417–421.
    1. Tsukayama D.T. Pathophysiology of posttraumatic osteomyelitis. Clin Orthop Relat Res. 1999;360:22–29.
    1. Maurer D.J., Marko R.L., Gustilo R.B. Infection after intramedullary nailing of severe open tibial fractures initially treated with external fixation. J Bone Joint Surg Am. 1989;71:835–838.
    1. Fuchs T., Stange R., Schmidmaier G. The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch Orthop Trauma Surg. 2011;131:1419–1425.
    1. Metsemakers W.J., Reul M., Nijs S. The use of Gentamicin-coated nails in complex open tibia fracture and revision cases: a retrospective analysis of a single centre case series and review of the literature. Injury. 2015;46:2433–2437.
    1. Hofmann A., Dietz S.O., Pairon P. The role of intramedullary nailing in treatment of open tibia fractures. Eur J Trauma Emerg Surg. 2015;41:39–47.
    1. Gaebler C., Berger U., Schandelmaier P. Rates and odds ratios for complications in closed and open tibial fractures treated with unreamed, small diameter tibial nails: a multicenter analysis of 467 cases. J Orthop Trauma. 2001;15:415–423.
    1. Gustilo R.B., Anderson J.T. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58:453–458.
    1. Ciampolini J., Harding K.G. Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad Med J. 2000;76:479–483.
    1. Calhoun J.H., Mader J.T. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin Orthop Relat Res. 1997;341:206–214.
    1. Lucke M., Schmidmaier G., Sadoni S. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone. 2003;32:521–531.
    1. Schmidmaier G., Wildemann B., Stemberger A. Biodegradable poly (D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res. 2001;58:449–455.
    1. Yasko A.W., Lane J.M., Fellinger E.J. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am. 1992;74:659–670.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する